These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2918 related articles for article (PubMed ID: 20107219)

  • 21. Anesthetics promoting in vitro AβPP metabolism and amyloid-β toxicity.
    Eckel B; Blobner M; Rammes G
    J Alzheimers Dis; 2010; 22 Suppl 3():21-6. PubMed ID: 20858965
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulation of gamma-secretase activity in Alzheimer's disease.
    Zhou S; Zhou H; Walian PJ; Jap BK
    Biochemistry; 2007 Mar; 46(10):2553-63. PubMed ID: 17298085
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Neurofibrillary tangles and early modification of the neuronal cytoskeleton in Alzheimer's disease and in experimental models].
    Brion JP
    Bull Mem Acad R Med Belg; 1999; 154(6 Pt 2):287-94. PubMed ID: 10992876
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Problems of the amyloid beta precursor protein in pathogenesis of the Alzheimer type dementia].
    Shoji M; Hirai S
    Nihon Ronen Igakkai Zasshi; 1996 Mar; 33(3):164-8. PubMed ID: 8648890
    [No Abstract]   [Full Text] [Related]  

  • 25. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics.
    Hardy J; Selkoe DJ
    Science; 2002 Jul; 297(5580):353-6. PubMed ID: 12130773
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pathogenesis of Alzheimer's disease].
    Alegre M; Noé E; Luquin MR
    Rev Med Univ Navarra; 1997; 41(1):46-57. PubMed ID: 9527714
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The molecular pathology of amyloid deposition in Alzheimer's disease.
    Martins RN; Robinson PJ; Chleboun JO; Beyreuther K; Masters CL
    Mol Neurobiol; 1991; 5(2-4):389-98. PubMed ID: 1823142
    [No Abstract]   [Full Text] [Related]  

  • 28. [Therapy of Alzheimer disease].
    Kovács T
    Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glucocorticoids increase impairments in learning and memory due to elevated amyloid precursor protein expression and neuronal apoptosis in 12-month old mice.
    Li WZ; Li WP; Yao YY; Zhang W; Yin YY; Wu GC; Gong HL
    Eur J Pharmacol; 2010 Feb; 628(1-3):108-15. PubMed ID: 19948164
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mitochondrial amyloid-beta peptide: pathogenesis or late-phase development?
    Yan SD; Xiong WC; Stern DM
    J Alzheimers Dis; 2006 Jul; 9(2):127-37. PubMed ID: 16873960
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amyloid precursor protein (APP) and beta A4 amyloid in the etiology of Alzheimer's disease: precursor-product relationships in the derangement of neuronal function.
    Beyreuther K; Masters CL
    Brain Pathol; 1991 Jul; 1(4):241-51. PubMed ID: 1669714
    [No Abstract]   [Full Text] [Related]  

  • 32. Oral administration of a potent and selective non-peptidic BACE-1 inhibitor decreases beta-cleavage of amyloid precursor protein and amyloid-beta production in vivo.
    Hussain I; Hawkins J; Harrison D; Hille C; Wayne G; Cutler L; Buck T; Walter D; Demont E; Howes C; Naylor A; Jeffrey P; Gonzalez MI; Dingwall C; Michel A; Redshaw S; Davis JB
    J Neurochem; 2007 Feb; 100(3):802-9. PubMed ID: 17156133
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alzheimer's disease-do tauists and baptists finally shake hands?
    Mudher A; Lovestone S
    Trends Neurosci; 2002 Jan; 25(1):22-6. PubMed ID: 11801334
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Structure and function analysis of gamma-secretase complex toward development of therapeutics for Alzheimer's disease].
    Tomita T
    Tanpakushitsu Kakusan Koso; 2009 Sep; 54(12 Suppl):1684-9. PubMed ID: 21089607
    [No Abstract]   [Full Text] [Related]  

  • 35. [Alzheimer's disease: lesions and their progression].
    Duyckaerts C; Colle MA; Delatour B; Hauw JJ
    Rev Neurol (Paris); 1999; 155 Suppl 4():S17-27. PubMed ID: 10637934
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Why nutraceuticals do not prevent or treat Alzheimer's disease.
    Fisher AE; Naughton DP
    Nutr J; 2005 Apr; 4():14. PubMed ID: 15826313
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [THE ROLE OF β-AMYLOID AND MITOCHONDRIAL DYSFUNCTION IN THE PATHOGENESIS OF ALZHEIMER'S DISEASE].
    Szarka A
    Ideggyogy Sz; 2015 Jul; 68(7-8):222-8. PubMed ID: 26380416
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Alzheimer's plaques, tangles and memory deficits may have a common origin; part I; a calcium deficit hypothesis.
    Chen M
    Front Biosci; 1998 May; 3():a27-31. PubMed ID: 9576681
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic potential of some stress mediators in early Alzheimer's disease.
    Pardon MC
    Exp Gerontol; 2011; 46(2-3):170-3. PubMed ID: 20870017
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Recent study on Alzheimer's disease].
    Hirai S
    Nihon Naika Gakkai Zasshi; 1993 Mar; 82(3):367-71. PubMed ID: 8315330
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 146.